Countries Already Buy Bitcoin ‘In Huge Volumes’, Says Novogratz

Este artículo también está disponible en español. Mike Novogratz, the founder and CEO of Galaxy Digital Holdings—a leading crypto investment firm listed on the Toronto Stock Exchange—has signaled a significant shift in the global adoption of Bitcoin. In a post on Tuesday via X, Novogratz declared that countries are already purchasing Bitcoin. Nation-State Bitcoin FOMO Is Real “Countries are already buying BTC in huge volumes—these are massive pools of capital entering the market. We’re witnessing global adoption at scale and the next rally could be massive. Buckle up. Caught up…

Grayscale will begin trading Bitcoin ETF options

Grayscale will start trading the Bitcoin ETF options for both products on November 21, following BlackRock’s IBIT options trading on the previous day, which reached $1.9 billion in a day. An American asset manager, Grayscale Investment LLC, announced on their X’s post on Nov. 20 that both of their Bitcoin spot ETF products will be available for options trading on Thursday. “Grayscale thrilled that Options trading on both $GBTC and $BTC will begin tomorrow, further the developing ecosystem around our U.S.-listed #Bitcoin ETP,” the company official X said. Grayscale Bitcoin Trust (GBTC)…

Bitcoin Rally Driven By U.S. Coinbase Investors – Top Analyst Shares Metrics

Este artículo también está disponible en español. Bitcoin reached a new all-time high yesterday, surging to $94,000 and solidifying the bulls’ control over the market. This milestone has ignited widespread speculation about the key factors fueling the rally, as Bitcoin continues to dominate headlines and capture investor enthusiasm.  Related Reading Key insights from CryptoQuant CEO Ki Young Ju shed light on the drivers of this historic surge. According to Ju, this rally has been powered by Coinbase investors, with U.S.-based buyers playing a significant role. The influx of demand from…

Onchain Analyst: Binance Taps Cold Wallet Reserves as Bitcoin Outflows Spike

According to the creator of timechainindex.com, Binance, one of the leading cryptocurrency exchanges, has recently experienced “significant outflows.” This activity has reportedly prompted the platform to tap into its cold wallet reserves to manage the situation. $334 Billion in Play: Centralized Exchanges Face Onchain Scrutiny Amid Bitcoin Highs The chatter on the onchain grapevine suggests […] Original

Analyst Predicts $200k Bitcoin On Incoming ‘Supply Shock’

Este artículo también está disponible en español. Crypto Rover, a prominent crypto analyst, has identified critical indicators in the market dynamics of Bitcoin, such as a decline in exchange reserves and a favorable chart pattern that suggests a price target of $200,000. Related Reading His analysis is consistent with Bernstein’s long-term projection, which serves to bolster the notion that Bitcoin may experience substantial growth in the years ahead. These predictions have investors and analysts alike anxiously anticipating Bitcoin’s next significant move, as the market is currently in flux. Decreasing Exchange…

The Subtle Way AI Data Centers Boost Bitcoin Mining Economics

“I don’t think the competition for power from AI facilities will significantly impact hashprice,” Mellerud said. “The Bitcoin mining network is a self-correcting mechanism, so reduced hashrate in one country will simply increase profitability of miners in another country, giving them more room to grow.” “My thesis is that the U.S. will have less than 20% of the hashrate by 2030 due to competition from AI facilities, while hashrate will grow elsewhere, particularly in Africa and Southeast Asia,” Mellerud added. Source

Acurx Pharmaceuticals Allocates $1 Million to Bitcoin as Reserve Asset, Shares Slide 26%

Acurx Pharmaceuticals Inc. has decided to take a bold financial step, pledging up to $1 million toward bitcoin (BTC) as a treasury reserve asset. This move signals a pivot in financial strategy for the late-stage biopharmaceutical company. Biopharma Firm Acurx Adopts Bitcoin for Treasury Strategy The board of directors at Acurx Pharmaceuticals (NASDAQ: ACXP) greenlit […] Original